Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MUHAMMAD A AHMAD

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1164500823
CMS profile
7063
Location
JERSEY CITY, NJ

General Payments · PY2018–2024

$4,400.32

  • Reported across 212 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$370.31

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $370.31 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,364.74 68
PY2019 $745.33 40
PY2020 $390.51 21
PY2021 $513.97 21
PY2022 $554.30 31
PY2023 $461.16 15
PY2024 $370.31 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $88.64 04/18/2024 Food and Beverage Undisputed 01/23/2026 1115411521 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.74 02/28/2024 Food and Beverage Undisputed 01/23/2026 1117898498 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.33 03/29/2024 Food and Beverage Undisputed 01/23/2026 1117898496 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.21 05/10/2024 Food and Beverage Undisputed 01/23/2026 1117898494 CMS
Exact Sciences Corporation $34.48 06/12/2024 Food and Beverage Undisputed 01/23/2026 1114571049 CMS
GlaxoSmithKline, LLC. $24.18 08/05/2024 Food and Beverage Undisputed 01/23/2026 1115987195 CMS
GlaxoSmithKline, LLC. $30.77 10/28/2024 Food and Beverage Undisputed 01/23/2026 1116595141 CMS
GlaxoSmithKline, LLC. $20.84 12/02/2024 Food and Beverage Undisputed 01/23/2026 1115767371 CMS
Janssen Pharmaceuticals, Inc $15.96 02/15/2024 Food and Beverage Undisputed 01/23/2026 1078091438 CMS
Phathom Pharmaceuticals, Inc. $15.73 04/02/2024 Food and Beverage Undisputed 01/23/2026 1151032832 CMS
Phathom Pharmaceuticals, Inc. $14.59 04/23/2024 Food and Beverage Undisputed 01/23/2026 1151032834 CMS
Phathom Pharmaceuticals, Inc. $16.13 05/28/2024 Food and Beverage Undisputed 01/23/2026 1151032836 CMS
Phathom Pharmaceuticals, Inc. $14.52 09/17/2024 Food and Beverage Undisputed 01/23/2026 1151032838 CMS
Phathom Pharmaceuticals, Inc. $17.45 10/15/2024 Food and Beverage Undisputed 01/23/2026 1151032840 CMS
Phathom Pharmaceuticals, Inc. $14.29 11/11/2024 Food and Beverage Undisputed 01/23/2026 1151032842 CMS
Phathom Pharmaceuticals, Inc. $14.45 12/10/2024 Food and Beverage Undisputed 01/23/2026 1151032844 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.